{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:11:41Z","timestamp":1790284301497,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ajg.2012.06.010","type":"journal-article","created":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T00:00:30Z","timestamp":1347321630000},"page":"161-165","source":"Crossref","is-referenced-by-count":22,"title":["Relationship between non-alcoholic fatty liver disease and kidney function: A communication between two organs that needs further exploration"],"prefix":"10.1016","volume":"13","author":[{"given":"Asma A.","family":"Hamad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atif A.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2012.06.010_b0005","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1681\/ASN.2005010112","article-title":"Projecting the number of patients with end-stage renal disease in the United States to the year 2015","volume":"16","author":"Gilbertson","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ajg.2012.06.010_b0010","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2012.06.010_b0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2012.06.010_b0020","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2012.06.010_b0025","doi-asserted-by":"crossref","unstructured":"Ahmed M.H., Abu E.O., Byrne C.D. Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities? Prim Care Diabetes 2010.","DOI":"10.1016\/j.pcd.2010.02.004"},{"key":"10.1016\/j.ajg.2012.06.010_b0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1463-1326.2008.00926.x","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"11","author":"Ahmed","year":"2009","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ajg.2012.06.010_b0035","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajg.2012.06.010_b0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1309\/JXWUM661T8VT1ETX","article-title":"Biochemical markers: the road map for the diagnosis of nonalcoholic fatty liver disease","volume":"127","author":"Ahmed","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ajg.2012.06.010_b0045","unstructured":"M.H. Ahmed, C.D. Byrne, Metabolic syndrome, diabetes & CHD risk. CJ Packard. The Year in Lipid Disorders, Oxford UK, clinical publishing, 2007, 3\u201326. Ref Type: Serial (Book, Monograph).."},{"key":"10.1016\/j.ajg.2012.06.010_b0050","series-title":"Non-Alcoholic Fatty Liver Disease as chapter in The Metabolic syndrome","author":"Ahmed","year":"2011"},{"key":"10.1016\/j.ajg.2012.06.010_b0055","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.numecd.2007.03.003","article-title":"Obesity and kidney disease","volume":"17","author":"Cignarelli","year":"2007","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.ajg.2012.06.010_b0060","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.metabol.2010.07.022","article-title":"Nonalcoholic steatohepatitis and increased risk of chronic kidney disease","volume":"60","author":"Yasui","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.ajg.2012.06.010_b0065","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s12072-011-9254-2","article-title":"Renal function and severity of bright liver. Relationship with insulin resistance, intrarenal resistive index, and glomerular filtration rate","volume":"5","author":"Catalano","year":"2011","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.ajg.2012.06.010_b0070","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2169\/internalmedicine.50.5043","article-title":"The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease","volume":"50","author":"Arase","year":"2011","journal-title":"Intern. Med."},{"key":"10.1016\/j.ajg.2012.06.010_b0075","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2007101155","article-title":"Increased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver Disease","author":"Targher","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ajg.2012.06.010_b0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1478-3231.2011.02623.x","article-title":"Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease","volume":"32","author":"Machado","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.ajg.2012.06.010_b0085","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00467-009-1134-9","article-title":"Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease","volume":"24","author":"Manco","year":"2009","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ajg.2012.06.010_b0090","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.2215\/CJN.05050610","article-title":"Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis","volume":"5","author":"Targher","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ajg.2012.06.010_b0095","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.drudis.2010.06.007","article-title":"Ezetimibe as a potential treatment for non-alcoholic fatty liver disease: is the intestine a modulator of hepatic insulin sensitivity and hepatic fat accumulation?","volume":"15","author":"Ahmed","year":"2010","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.ajg.2012.06.010_b0100","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.11861111","article-title":"Chronic Kidney Disease, Insulin Resistance, and Incident Diabetes in Older Adults","author":"Pham","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ajg.2012.06.010_b0105","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2011-2658","article-title":"Metabolic Syndrome and Insulin Resistance as Risk Factors for Development of Chronic Kidney Disease and Rapid Decline in Renal Function in Elderly","author":"Cheng","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ajg.2012.06.010_b0110","article-title":"Impact of Activated Vitamin D on Insulin Resistance in Non-diabetic Chronic Kidney Disease Patients","author":"Friedman","year":"2011","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ajg.2012.06.010_b0115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/clc.20901","article-title":"Insulin resistance, inflammation, and vascular disease in nondiabetic predialysis chronic kidney disease patients","volume":"34","author":"Banerjee","year":"2011","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ajg.2012.06.010_b0120","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/ndt\/gfq817","article-title":"Correlates of insulin resistance in older individuals with and without kidney disease","volume":"26","author":"Landau","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ajg.2012.06.010_b0125","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1525-139X.2010.00763.x","article-title":"Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease","volume":"23","author":"Siew","year":"2010","journal-title":"Semin. Dial."},{"key":"10.1016\/j.ajg.2012.06.010_b0130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5414\/CNP71643","article-title":"Insulin resistance is a risk factor for the progression of chronic kidney disease","volume":"71","author":"Kobayashi","year":"2009","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.ajg.2012.06.010_b0135","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.drudis.2007.07.009","article-title":"Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD)","volume":"12","author":"Ahmed","year":"2007","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.ajg.2012.06.010_b0140","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ajg.2012.06.010_b0145","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/jcp.2006.040410","article-title":"Obesity-related glomerulopathy: another nail in the coffin of the epidemic of end-stage renal disease","volume":"60","author":"Ahmed","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ajg.2012.06.010_b0150","first-page":"15","article-title":"Metabolic syndrome and its components associated with endothelial dysfunction in chronic kidney disease patients","volume":"8","author":"Bai","year":"2012","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ajg.2012.06.010_b0155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1900\/RDS.2011.8.276","article-title":"The frequency of prediabetes and contributing factors in patients with chronic kidney disease","volume":"8","author":"Razeghi","year":"2011","journal-title":"Rev. Diab. Stud."},{"key":"10.1016\/j.ajg.2012.06.010_b0160","article-title":"Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals","author":"Johns","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ajg.2012.06.010_b0165","first-page":"949","article-title":"Prevalence of chronic kidney disease in adults with metabolic syndrome","volume":"22","author":"Emem-Chioma","year":"2011","journal-title":"Saudi J. Kidney Dis. Transpl."},{"issue":"133\u201341","key":"10.1016\/j.ajg.2012.06.010_b0170","first-page":"148","article-title":"Identification of modifiable chronic kidney disease risk factors by gender in an African-American metabolic syndrome cohort","volume":"37","author":"Brown","year":"2010","journal-title":"Nephrol. Nurs. J."},{"key":"10.1016\/j.ajg.2012.06.010_b0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1440-1797.2009.01091.x","article-title":"Association between metabolic syndrome and chronic kidney disease in the Korean population","volume":"14","author":"Chang","year":"2009","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ajg.2012.06.010_b0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1440-1797.2009.01150.x","article-title":"Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort","volume":"15","author":"Sun","year":"2010","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ajg.2012.06.010_b0185","first-page":"176","article-title":"Metabolic syndrome and its relation to chronic kidney disease in a Southeast Asian population","volume":"42","author":"Satirapoj","year":"2011","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.ajg.2012.06.010_b0190","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/met.2011.0040","article-title":"Metabolic syndrome, cardiovascular disease, and risk for chronic kidney disease in an Italian cohort: analysis of the INCIPE study","volume":"9","author":"Ferraro","year":"2011","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.ajg.2012.06.010_b0195","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.2215\/CJN.02180311","article-title":"Metabolic syndrome and kidney disease: a systematic review and meta-analysis","volume":"6","author":"Thomas","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ajg.2012.06.010_b0200","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1463-1326.2010.01261.x","article-title":"Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events","volume":"12","author":"Ahmed","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ajg.2012.06.010_b0205","first-page":"1021","article-title":"Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant","volume":"21","author":"Ahmed","year":"2010","journal-title":"Saudi J. Kidney. Dis. Transpl."},{"issue":"Suppl 7","key":"10.1016\/j.ajg.2012.06.010_b0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-6135.2004.0355.x","article-title":"Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ajg.2012.06.010_b0215","doi-asserted-by":"crossref","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences","volume":"290","author":"Vaziri","year":"2006","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.ajg.2012.06.010_b0220","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.metabol.2005.01.028","article-title":"Insulin resistance and postprandial triglyceride levels in primary renal disease","volume":"54","author":"Charlesworth","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.ajg.2012.06.010_b0225","first-page":"F925","article-title":"Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure","volume":"273","author":"Vaziri","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ajg.2012.06.010_b0230","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0272-6386(00)70255-1","article-title":"Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation","volume":"35","author":"Deighan","year":"2000","journal-title":"Am. J. Kidney Dis."}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197912000858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197912000858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T23:01:19Z","timestamp":1542754879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197912000858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1687197912000858"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2012.06.010","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}